[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]methyl (15R)-15-hydroxy-1-(1H-indol-3-yl)-16,16-dimethyl-4,10,14-trioxo-6-thia-3,9,13-triazaheptadecan-17-yl dih ydrogen diphosphate

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]methyl (15R)-15-hydroxy-1-(1H-indol-3-yl)-16,16-dimethyl-4,10,14-trioxo-6-thia-3,9,13-triazaheptadecan-17-yl dih ydrogen diphosphate

[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]methyl-(15R)-15-hydroxy-1-(1H-indol-3-yl)-16,16-dimethyl-4,10,14-trioxo-6-thia-3,9,13-triazaheptadecan-17-yldihy drogendiphosphat

Adenosine, 5′-O-[hydroxy[[hydroxy[[(3R)-3-hydroxy-17-(1H-indol-3-yl)-2,2-dimethyl-4,8,14-trioxo-12-thia-5,9,15-triazaheptadec-1-yl]oxy]phosphinyl]oxy]phosphinyl]-, 3′-(dihydrogen phosphate)

Dihydrogénodiphosphate de [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tétrahydro-2-furanyl]méthyle et de (15R)-15-hydroxy-1-(1H-indol-3-yl)-16,16-diméthyl-4,10,14-trioxo-6-thia- 3,9,13-triazaheptadécan-17-yle

coa-s-acetyl tryptamine

COT